The following sessions will be presented at the upcoming 2013 Collaborative Perspectives on Addiction Conference. Earlybird registration ends March 21! www.tinyurl.com/2013CPA
>BEHAVIORAL ECONOMIC PERSPECTIVES ON ADDICTION
The field of behavioral economics, or the study of economic decision-making with behavioral experimentation, has contributed a great deal to the understanding of addiction and the altered decision-making patterns often seen in addiction. In this session, four behavioral economic researchers (Warren Bickel, James MacKillop, James Murphy, and Mikhail Koffarnus) will present recent research in this area and discuss the unique contributions of behavioral economics to the understanding of addiction.
Warren Bickel, PhD; Mikhail Koffarnus, PhD; James MacKillop, PhD; James Murphy, PhD
>APPLYING CLINICAL NEUROSCIENCE TO THE TREATMENT OF ADDICTION
Addiction is a chronic and relapsing disorder affecting millions of patients worldwide. Extensive preclinical research has elucidated some of the key neurobiological underpinnings of addiction, yet these findings have not been translated into clinical practice. This workshop will review addiction neurobiology while applying theses insights to the understanding of the clinical phenomenology and treatment of the disorder. Participants will learn how to integrate key findings from addiction neuroscience into the psychological treatment of addiction.
Kelly Courtney, PhD; Lara Ray, PhD
>BIOBEHAVIORAL PERSPECTIVES ON MECHANISMS OF BEHAVIOR CHANGE: BRAIN, BODY, MIND, AND CONTEXT
This session will introduce some “out of the box” biobehavioral perspectives on research and practice approaches to identifying and manipulating mechanisms of behavior change in addictions. The construct of arousal will be probed at the level of the brain, the body, the mind, and in social interaction. Implications for developing a multi-level explanatory framework to understand behavior change will be discussed. Video clips and audience-involved demonstrations will be included.
Marsha Bates, PhD; David Eddie, MS; Jon Morgenstern, PhD; Robert Zucker, PhD, ABPP
>CO-MORBID INHALANT USE AND COMPULSORY BEHAVIORS: IMPLICATIONS FOR RED-FLAG ASSESSMENTS AND STRATEGIES FOR CLINICAL CARE
The present study explored the relationship between compulsory behaviors, trauma history, and increased prevalence of inhalant abuse in females versus males in adolescent substance users. A major focus of this study was to provide practical guidelines for clinicians treating adolescents with substance use disorders by way of assessment and treatment planning strategies. The findings are tied directly into strategies for treatment planning in a tangible attempt to bridge the divide between research and clinical practice.
Robert Daniels, MA; Tommi Rivers, BA
>INTERDISCIPLINARY TREATMENT TEAMS FOR ADDICTIVE DISORDERS ON COLLEGE CAMPUSES
This symposium describes the methods and benefits of integrated, interdisciplinary treatment team approaches for eating disorders and alcohol and other drug (AOD) abuse on a college campus.
Irene Dalton, PhD; Abby Myers, PhD; Shannon Croft, MD; Kelita Wiley, MD
>MEDIATORS OF THE ASSOCIATION OF DEPRESSION WITH SMOKING CESSATION
This study examined the mechanisms linking depression to smoking cessation in an ethnically diverse sample (N=424). Greater depression was associated with significantly lower cessation rates. Positive affect, stress, self-efficacy, expectancies of controlling negative affect by means other than smoking, affective withdrawal symptoms, and social support individually mediated the effect of depression on smoking cessation. However, when taking into account other significant mediators, only self-efficacy and sadness uniquely mediated the effect of depression on smoking cessation.
Virmarie Correa Fernandez, PhD; Whitney L. Heppner, PhD; Diana Stewart, PhD; Amanda Mathew, MA
>MEDICATION DEVELOPMENT: TRANSLATING RESEARCH INTO PRACTICE
This breakout session examines the development and implementation of medication for the treatment of alcohol and drug use disorders. Presentation 1 discusses development of an immunotherapy for methamphetamine use. Presentation 2 reports on the system changes required to promote the use of medication. Presentation 3 examines the use of medication within addiction treatment centers. Presentation 4 is a case study of medication use in a community-based treatment center participating in the Clinical Trials Network.
John Gardin; Jennifer Loftis; Dennis McCarth; Traci Rieckmann
>NEUROECONOMICS AS A FRAMEWORK FOR TRANSLATIONAL RESEARCH ON ADDICTION
Neuroeconomics is an interdisciplinary research approach that has characterized neural abnormalities underlying pathological decision making in individuals who misuse a variety of substances. The four talks in this session will highlight recent neuroeconomics research in addiction with a particular focus on neuroimaging studies of impulsive delay discounting and substance demand along with pharmacological and genetic influences on these variables. An interactive panel discussion will focus on translational implications for interventions for addictive disorders.
Michael Amlung, MS; Charlotte Boettiger, PhD; James MacKillop, PhD; Joseph Schacht, PhD
>THE APPLICATION OF CLINICAL NEUROSCIENCE IN TREATING ADDICTIVE DISORDERS
This symposium highlights the application of clinical neuroscience in understanding and treating addictive disorders. Review of recent studies and the role of psychopharmacology and integrative treatment will be discussed.
Meghan Marcum, PsyD
>UNDERSTANDING AND TREATING THE CO-OCCURRING DISORDERED CLIENT
This session will explore the underlying characteristics of individuals with confounding mental health and substance use disorder issues and will explore specific treatment strategies for this population.
Vito DonGiovanni, PhD
EARLY REGISTRATION ENDS MARCH 21!
· Conference Website, Registration, and Hotel: www.tinyurl.com/2013CPA
· See who’s registered so far! https://divisions.wufoo.com/reports/2013-cpa-attendee-directory/
· See all the details on the attached Brochure
ABOUT THE CONFERENCE
The theme for the 2013 conference is "Biobehavioral RESEARCH & Implications for PRACTICE"
· Atlanta, Georgia / May 3-4, 2013
· Two thought-provoking keynote sessions
· Interactive environment for collaboration/networking
· Several breakout session choices
· Poster Sessions
· Pre-conference in-depth workshops
· Discounted rates for Early Career Psychologists
· Student opportunities (discounted rates, special networking, etc)
· You don't have to be a member of either or division or APA to attend the conference!
· 13.5 hours of CE are available AND included in the price
MEET THE KEYNOTERS
· Saul Shiffman, PhD, is a world-renowned researcher in the fields of behavior change and relapse, self-management and self-control, field research methodology, statistical analysis, and addiction and dependence. Since 1991, he has been a professor in the departments of psychology and pharmaceutical science at the University of Pittsburgh. Dr. Shiffman has taught in the departments of psychology and psychiatry and behavioral medicine at various universities, including the University of South Florida, the University of Washington, and the University of Pittsburgh. Dr. Shiffman has authored or co-authored over 300 published papers on a variety of topics related to psychopharmacology, substance abuse, dependence, relapse, coping, and computerized assessments of behavior, and has presented widely in medical and scientific forums. A fellow of numerous professional societies (including APA Divisions 28 and 50), Dr. Shiffman was awarded the Society for Research on Nicotine and Tobacco’s Ovid Ferno Award for “ground breaking advances in clinical research.”
· Edith V. Sullivan, PhD, is professor of psychiatry and behavioral sciences at Stanford University School of Medicine and a neuropsychologist who has pioneered the study of alcoholism-related brain injury on selective cognitive and motor function. She is the recipient of a Senior Scientist Research and Mentorship Award, a grant for international collaborations on alcoholism research, and an NIAAA MERIT award for studies of neural circuitry modification in alcoholism focused on frontocerebellar systems. Dr. Sullivan is a recipient of the Research Society on Alcoholism Distinguished Researcher Award and is author of more than 250 peer-reviewed papers and numerous chapters and reviews. Dr. Sullivan will present a keynote address on Saturday, May 4, titled “Alcoholism and the Brain: Road to Ruin and Path to Recovery.”
PRE-CONFERENCE WORKSHOP
"Conducting Neuroimaging Studies from a Neuropsychologist’s Perspective"
Integrating neuroimaging techniques with neuropsychological and other neurobehavioral methods is often a powerful approach in human studies. Many applicants underappreciate the critical processes that enable a) identification of appropriate team members, b) building cohesion among members, and c) sustaining individual commitment and engagement throughout the project. Furthermore, psychologists without neuroimaging expertise often fail to fully utilize the expertise of their collaborators and thus struggle to communicate the import of their data. Building on existing literature and her own experiences, Dr. Mattson’s workshop focuses on essential steps in defining effective, productive and innovative teams from the perspective of “non-imagers.”
Presenter: Sarah Mattson, PhD (Pre-Registration Required)
LUNCHEON PRESENTATION
“Peeking Behind the Curtain of the NIH Funding Process: Tips for Preparing a Successful Grant Application”
Applying for NIH research funding can be a daunting prospect, especially in a tough budget environment, yet thousands of submissions are funded in every cycle. Successful applications are not just based on important and innovative ideas but how those ideas are formulated and presented. Dr. Harold Perl is a 23-year veteran of NIDA and NIAAA. He presents an in-depth analysis of the application process that will help investigators at all levels enhance their grantsmanship and increase their chances of success. Attendees also will get an illuminating behind-the-scenes look at the review and funding process from this key NIH “insider.”
Presenter: Harold Perl, PhD, the Chief of the Prevention Research Branch at NIDA. Presentation includes complimentary luncheon; all attendees welcome.
ABOUT THE VENUE
The beautiful W Hotel in Midtown Atlanta will be the venue for our First Annual Conference. The hotel is located in the heart of Midtown and is local to public transportation. Room rates are $159 per night. Reserve your room now!
MORE INFORMATION
Sara Jo Nixon, PhD, Conference Chair
Anthony Liguori, PhD, Conference Co-Chair
John Kelly, PhD, Sponsorship Co-Chair
Katie Witkiewitz, PhD, Sponsorship Co-Chair
Jennifer Buckman, PhD, Conference Treasurer
Chad Rummel, MEd, Registration and Hotel Accommodations (202-336-6121)
Conference Website and Registration: www.tinyurl.com/2013CPA
